Skip to main content

JPML To Consolidate Zantac Lawsuits

JPML To Consolidate Zantac Lawsuits

JPML To Consolidate Zantac Lawsuits

Introduction

The U.S Judicial Panel on Multidistrict Litigation (JPML) has decided to consolidate and centralize the growing number of Zantac lawsuits before U.S. District Judge Robin L. Rosenberg in Florida for coordinated discovery and pretrial proceedings.

There are more than 140 product liability and class action lawsuits pending in two dozen different federal court districts nationwide. Each lawsuit has similar allegations, stating that the active ingredient in Zantac, ranitidine, produces high levels of the known human carcinogen Nitrosodimethylamine (NDMA). Plaintiffs claimed that exposure to the chemical for extended periods of time caused them to develop bladder cancer, kidney cancer, colorectal cancer, stomach cancer, and other forms of cancer along the digestive tract.

A citizen’s petition was filed with the FDA in September 2019, which resulted in the recall of Zantac indicating the drug should be considered a human carcinogen. In November, a group of plaintiffs filed a motion to centralize lawsuits as part of a federal MDL. Following the motion, the JPML issued a transfer order last week for consolidation.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

Oregon to Get $66M in Sackler Opioid Settlement

Categories: Opioids

Oregon will gain $66 million as part of a nationwide settlement with the Sackler family and Purdue Pharma, the makers of OxyContin. The funds will be used to expand and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!